| Literature DB >> 35245133 |
Janet R Manning1,2,3, Dharendra Thapa1,2,3, Manling Zhang1,2,3, Michael W Stoner1,2,3, John C Sembrat4, Mauricio Rojas5, Iain Scott1,2,3.
Abstract
Reversible lysine acetylation regulates the activity of cardiac metabolic enzymes, including those controlling fuel substrate metabolism. Mitochondrial-targeted GCN5L1 and SIRT3 have been shown to regulate the acetylation status of mitochondrial enzymes, but the role that lysine acetylation plays in driving metabolic differences between male and female hearts is not currently known. In this study, we describe a significant difference in GCN5L1 levels between male and female mouse hearts, and in the hearts of women between post- and premenopausal age. We further find that estrogen drives GCN5L1 expression in a cardiac cell line and uses pharmacological approaches to determine the mechanism to be G protein-coupled estrogen receptor (GPER) activation, via translational regulation.NEW & NOTEWORTHY We demonstrate here for the first time that mitochondrial protein acetylation is increased in female hearts, associated with an increase in GCN5L1 levels through a GPER-dependent mechanism. These findings reveal a new potential mediator of divergent cardiac mitochondrial function between men and women.Entities:
Keywords: GCN5L1; GPER; SIRT3; acetylation; estrogen
Mesh:
Substances:
Year: 2022 PMID: 35245133 PMCID: PMC8977132 DOI: 10.1152/ajpheart.00024.2022
Source DB: PubMed Journal: Am J Physiol Heart Circ Physiol ISSN: 0363-6135 Impact factor: 4.733